» Articles » PMID: 37509529

Fabrication of a Smart Fibrous Biomaterial That Harbors an Active TGF-β1 Peptide: A Promising Approach for Cartilage Regeneration

Overview
Journal Biomedicines
Date 2023 Jul 29
PMID 37509529
Authors
Affiliations
Soon will be listed here.
Abstract

The regeneration of articular cartilage remains a serious problem in various pathological conditions such as osteoarthritis, due to the tissue's low self-healing capacity. The latest therapeutic approaches focus on the construction of biomaterials that induce cartilage repair. This research describes the design, synthesis, and investigation of a safe, "smart", fibrous scaffold containing a genetically incorporated active peptide for chondrogenic induction. While possessing specific sequences and the respective mechanical properties from natural fibrous proteins, the fibers also incorporate a Transforming Growth Factor-β1 (TGF-β1)-derived peptide (YYVGRKPK) that can promote chondrogenesis. The scaffold formed stable porous networks with shear-thinning properties at 37 °C, as shown by SEM imaging and rheological characterization, and were proven to be non-toxic to human dental pulp stem cells (hDPSCs). Its chondrogenic capacity was evidenced by a strong increase in the expression of specific chondrogenesis gene markers , , , and in cells cultured on "scaffold-TGFβ1" for 21 days and by increased phosphorylation of intracellular signaling proteins Smad-2 and Erk-1/2. Additionally, intense staining of glycosaminoglycans was observed in these cells. According to our results, "scaffold-TGFβ1" is proposed for clinical studies as a safe, injectable treatment for cartilage degeneration.

Citing Articles

Bioactive peptides and proteins for tissue repair: microenvironment modulation, rational delivery, and clinical potential.

Hao Z, Zhang Z, Wang Z, Wang Y, Chen J, Chen T Mil Med Res. 2024; 11(1):75.

PMID: 39639374 PMC: 11619216. DOI: 10.1186/s40779-024-00576-x.


In Vitro Chondrogenesis Induction by Short Peptides of the Carboxy-Terminal Domain of Transforming Growth Factor β1.

Pitou M, Papachristou E, Bratsios D, Kefala G, Tsagkarakou A, Leonidas D Biomedicines. 2023; 11(12).

PMID: 38137403 PMC: 10740954. DOI: 10.3390/biomedicines11123182.

References
1.
Strzalka W, Ziemienowicz A . Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation. Ann Bot. 2010; 107(7):1127-40. PMC: 3091797. DOI: 10.1093/aob/mcq243. View

2.
Machado R, da Costa A, Sencadas V, Garcia-Arevalo C, Costa C, Padrao J . Electrospun silk-elastin-like fibre mats for tissue engineering applications. Biomed Mater. 2013; 8(6):065009. DOI: 10.1088/1748-6041/8/6/065009. View

3.
Verrecchio A, Germann M, Schick B, Kung B, Twardowski T, San Antonio J . Design of peptides with high affinities for heparin and endothelial cell proteoglycans. J Biol Chem. 2000; 275(11):7701-7. DOI: 10.1074/jbc.275.11.7701. View

4.
Karageorgiou V, Tomkins M, Fajardo R, Meinel L, Snyder B, Wade K . Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 in vitro and in vivo. J Biomed Mater Res A. 2006; 78(2):324-34. DOI: 10.1002/jbm.a.30728. View

5.
Girotti A, Fernandez-Colino A, Lopez I, Rodriguez-Cabello J, Arias F . Elastin-like recombinamers: biosynthetic strategies and biotechnological applications. Biotechnol J. 2011; 6(10):1174-86. DOI: 10.1002/biot.201100116. View